Cancer Deaths Projected to Rise 75% by 2050
- This report summarizes key findings from a study published in The Lancet regarding global cancer statistics, projections, and disparities.
- * Overall Increase: A rapid increase in global cancer cases and deaths occurred between 1990 and 2023, despite advancements in treatment and risk factor mitigation.
- * New Cases: More than doubled, reaching 18.5 million in 2023.
Cancer Statistics: Global Trends & Projections (2024-2050)
This report summarizes key findings from a study published in The Lancet regarding global cancer statistics, projections, and disparities.
key Findings:
* Overall Increase: A rapid increase in global cancer cases and deaths occurred between 1990 and 2023, despite advancements in treatment and risk factor mitigation.
* 2050 Projections:
* New Diagnoses: 30.5 million (a 61% increase from 2024).
* Deaths: 18.6 million (almost a 75% increase).
* Driving Factors: population growth and aging are the primary drivers of the projected increase in cases and deaths. Age-adjusted rates show no increase, indicating improvements in treatment are being offset by demographic changes.
* Disparities: More than half of new cases and two-thirds of deaths are expected to occur in low- and medium-income countries. Some medium- and low-income countries are experiencing increasing age-adjusted mortality rates.
* UN Lasting Growth Goal: Current trends are far from meeting the UN target of reducing premature mortality from noncommunicable diseases (including cancer) by one-third by 2030.
* Funding & Policy: cancer control policies and funding are insufficient, notably in resource-limited settings. Equitable access to diagnostics, treatment, and supportive care is crucial.
Historical Data (1990-2023):
* New Cases: More than doubled, reaching 18.5 million in 2023.
* Deaths: Increased by 74% to 10.4 million (excluding non-melanoma skin cancers).
Country-Specific Data (1990-2023 – Highest Increases):
| Country | Incidence Rate Increase (%) | Mortality Rate Increase (%) |
|---|---|---|
| Lebanon | 162.2% | 80% |
| United Arab Emirates | Data not fully provided in text | Data not fully provided in text |
Vital Note: The study analyzed data from 204 countries and territories across 47 cancers or groups of cancers.
Data Source: Global Burden of Disease Study Cancer Collaborators, published in The Lancet.